GB201917320D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201917320D0
GB201917320D0 GBGB1917320.2A GB201917320A GB201917320D0 GB 201917320 D0 GB201917320 D0 GB 201917320D0 GB 201917320 A GB201917320 A GB 201917320A GB 201917320 D0 GB201917320 D0 GB 201917320D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1917320.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Priority to GBGB1917320.2A priority Critical patent/GB201917320D0/en
Publication of GB201917320D0 publication Critical patent/GB201917320D0/en
Priority to KR1020227018623A priority patent/KR20220082092A/en
Priority to PL20816375.8T priority patent/PL3873883T3/en
Priority to DK20816376.6T priority patent/DK3844147T3/en
Priority to NZ788543A priority patent/NZ788543A/en
Priority to EP22214748.0A priority patent/EP4180037A1/en
Priority to IL292753A priority patent/IL292753B2/en
Priority to HRP20220797TT priority patent/HRP20220797T1/en
Priority to JP2022526073A priority patent/JP7422473B2/en
Priority to EP20816376.6A priority patent/EP3844147B1/en
Priority to AU2020381103A priority patent/AU2020381103B2/en
Priority to PT208163766T priority patent/PT3844147T/en
Priority to PCT/EP2020/081503 priority patent/WO2021089873A1/en
Priority to ES20816375T priority patent/ES2940811T3/en
Priority to HRP20230281TT priority patent/HRP20230281T1/en
Priority to CN202080087092.5A priority patent/CN114829341B/en
Priority to KR1020237033500A priority patent/KR20230142817A/en
Priority to CA3160337A priority patent/CA3160337C/en
Priority to JP2022526074A priority patent/JP7423131B2/en
Priority to HUE20816376A priority patent/HUE059403T2/en
Priority to ES20816376T priority patent/ES2920681T3/en
Priority to PCT/EP2020/081502 priority patent/WO2021089872A1/en
Priority to CN202080087091.0A priority patent/CN114829340B/en
Priority to MX2022005399A priority patent/MX2022005399A/en
Priority to EP20816375.8A priority patent/EP3873883B1/en
Priority to CA3160334A priority patent/CA3160334A1/en
Priority to AU2020378647A priority patent/AU2020378647B2/en
Priority to BR112022008919A priority patent/BR112022008919A2/en
Priority to HUE20816375A priority patent/HUE061482T2/en
Priority to PL20816376.6T priority patent/PL3844147T3/en
Priority to PT208163758T priority patent/PT3873883T/en
Priority to US17/412,828 priority patent/US11643390B2/en
Priority to IL292754A priority patent/IL292754A/en
Priority to US17/662,261 priority patent/US11578039B2/en
Priority to US18/152,465 priority patent/US20230167056A1/en
Priority to US18/193,866 priority patent/US20230250059A1/en
Priority to JP2023202672A priority patent/JP2024028798A/en
Ceased legal-status Critical Current

Links

GBGB1917320.2A 2019-11-07 2019-11-28 Novel compounds Ceased GB201917320D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB1917320.2A GB201917320D0 (en) 2019-11-28 2019-11-28 Novel compounds
PL20816375.8T PL3873883T3 (en) 2019-11-07 2020-11-09 Method of synthesis
JP2022526074A JP7423131B2 (en) 2019-11-07 2020-11-09 Compound
ES20816376T ES2920681T3 (en) 2019-11-07 2020-11-09 compounds
DK20816376.6T DK3844147T3 (en) 2019-11-07 2020-11-09 CONNECTIONS
HUE20816376A HUE059403T2 (en) 2019-11-07 2020-11-09 Compounds
EP22214748.0A EP4180037A1 (en) 2019-11-07 2020-11-09 Method of synthesis
IL292753A IL292753B2 (en) 2019-11-07 2020-11-09 Compounds, compositions comprising same, and uses thereof in the treatment of psychiatric or neurological disorders
HRP20220797TT HRP20220797T1 (en) 2019-11-07 2020-11-09 Compounds
JP2022526073A JP7422473B2 (en) 2019-11-07 2020-11-09 Synthesis method
EP20816376.6A EP3844147B1 (en) 2019-11-07 2020-11-09 Compounds
AU2020381103A AU2020381103B2 (en) 2019-11-07 2020-11-09 Compounds
PT208163766T PT3844147T (en) 2019-11-07 2020-11-09 Compounds
PCT/EP2020/081503 WO2021089873A1 (en) 2019-11-07 2020-11-09 Method of synthesis
ES20816375T ES2940811T3 (en) 2019-11-07 2020-11-09 Synthesis method
HRP20230281TT HRP20230281T1 (en) 2019-11-07 2020-11-09 Method of synthesis
CN202080087092.5A CN114829341B (en) 2019-11-07 2020-11-09 Synthesis method
KR1020237033500A KR20230142817A (en) 2019-11-07 2020-11-09 Compounds
CA3160337A CA3160337C (en) 2019-11-07 2020-11-09 Method of synthesis
KR1020227018623A KR20220082092A (en) 2019-11-07 2020-11-09 compound
NZ788543A NZ788543A (en) 2019-11-07 2020-11-09 Dimethyltryptamine derivatives and their use in psychedelic-assisted psychotherapy
PT208163758T PT3873883T (en) 2019-11-07 2020-11-09 Method of synthesis
CN202080087091.0A CN114829340B (en) 2019-11-07 2020-11-09 Compounds of formula (I)
PCT/EP2020/081502 WO2021089872A1 (en) 2019-11-07 2020-11-09 Compounds
MX2022005399A MX2022005399A (en) 2019-11-07 2020-11-09 Compounds.
EP20816375.8A EP3873883B1 (en) 2019-11-07 2020-11-09 Method of synthesis
CA3160334A CA3160334A1 (en) 2019-11-07 2020-11-09 Compounds
AU2020378647A AU2020378647B2 (en) 2019-11-07 2020-11-09 Method of synthesis
BR112022008919A BR112022008919A2 (en) 2019-11-07 2020-11-09 COMPOUND AND METHOD FOR TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS
HUE20816375A HUE061482T2 (en) 2019-11-07 2020-11-09 Method of synthesis
PL20816376.6T PL3844147T3 (en) 2019-11-07 2020-11-09 Compounds
US17/412,828 US11643390B2 (en) 2019-11-07 2021-08-26 Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses
IL292754A IL292754A (en) 2019-11-07 2022-05-03 Method of synthesis
US17/662,261 US11578039B2 (en) 2019-11-07 2022-05-06 Compounds
US18/152,465 US20230167056A1 (en) 2019-11-07 2023-01-10 Compounds
US18/193,866 US20230250059A1 (en) 2019-11-07 2023-03-31 Synthesis of n,n-dimethyltryptamine-type compounds, methods, and uses
JP2023202672A JP2024028798A (en) 2019-11-07 2023-11-30 Compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1917320.2A GB201917320D0 (en) 2019-11-28 2019-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB201917320D0 true GB201917320D0 (en) 2020-01-15

Family

ID=69147168

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1917320.2A Ceased GB201917320D0 (en) 2019-11-07 2019-11-28 Novel compounds

Country Status (1)

Country Link
GB (1) GB201917320D0 (en)

Similar Documents

Publication Publication Date Title
GB201902327D0 (en) Novel compounds
GB201905375D0 (en) Novel compounds
GB201912674D0 (en) Novel compounds
GB201905371D0 (en) Novel compounds
GB201905721D0 (en) Compounds
GB201918587D0 (en) Novel compounds
IL289627A (en) Novel pfar-inhibiting compounds
GB201910305D0 (en) Compounds
GB201913548D0 (en) Novel compounds
GB201908536D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201918076D0 (en) Novel compounds
GB201917863D0 (en) Novel compounds
GB201917320D0 (en) Novel compounds
GB201915129D0 (en) Novel compounds
GB201914623D0 (en) Novel compounds
GB201914624D0 (en) Novel compounds
GB201912836D0 (en) Novel compounds
GB201912865D0 (en) Novel compounds
GB201911960D0 (en) Novel compounds
GB201911777D0 (en) Novel compounds
GB201911781D0 (en) Novel compounds
GB201911717D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)